COVID-19 Clinical Trials in Baltimore, Maryland
10 recruitingBaltimore, Maryland
Showing 1–10 of 10 trials
Recruiting
Phase 1
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID)140 enrolled8 locationsNCT07221162
Recruiting
Phase 3
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Pfizer300 enrolled132 locationsNCT07013474
Recruiting
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
COVID-19
BioNTech SE25,500 enrolled208 locationsNCT07300839
Recruiting
Not Applicable
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
COVID-19Vaccine
Johns Hopkins University900 enrolled1 locationNCT06128928
Recruiting
Not Applicable
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
VA Office of Research and Development80 enrolled1 locationNCT05425264
Recruiting
Phase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Pfizer160 enrolled73 locationsNCT05261139
Recruiting
Not Applicable
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
FatiguePost-Acute COVID-19 Syndrome
University of Maryland, Baltimore56 enrolled1 locationNCT05977179
Recruiting
The Impact of COVID-19 on Maternal and Neonatal Outcomes
COVID-19Pregnancy; Infection
Johns Hopkins University300 enrolled1 locationNCT05197621
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922